RareSearch logo

Seattle Children's Hospital Research Institute - Center for Global Infectious Disease Research

50+ personnel
Headquartered in Chandler
Established in 2026
Website
Helen Erdman profile

Helen Erdman

🇮🇹 Italy

9.1

    Reviewed:

  • - Pharmacovigilance Services
  • - Ongoing
  • - Pharmaceutical Company

Highly effective pharmacovigilance services, ensured compliance.

The pharmacovigilance services ensured that our post-market surveillance was compliant and effective. The team was proactive in monitoring and reporting, providing us with peace of mind and ensuring patient safety.

Kerry Stiedemann profile

Kerry Stiedemann

🇰🇷 South Korea

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Fredrick Runte profile

Fredrick Runte

🇮🇳 India

9

    Reviewed:

  • - Biomarker Development
  • - 12 weeks October 2023 - January 2024
  • - Research Institution

Efficient and precise biomarker development.

The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.

Dr. Natasha Nienow profile

Dr. Natasha Nienow

🇮🇳 India

9.2

    Reviewed:

  • - Data Visualization
  • - 3 weeks December 2023
  • - Pharmaceutical Company

Highly effective data visualization, easy to interpret and impactful.

The data visualization services were highly effective, making complex data easy to interpret and communicate. The visualizations were impactful and played a crucial role in our stakeholder presentations.

Rosie Ortiz profile

Rosie Ortiz

🇹🇷 Turkey

6.2

    Reviewed:

  • - Clinical Protocol Design
  • - 10 weeks January - March 2024
  • - Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.